Year: 2018
Type: article
Abstract: Macroautophagy/autophagy is an evolutionarily conserved catabolic pathway whose modulation has been linked to diverse disease states, including age-associated disorders. Conventional and conditional whole-body knockout mouse models of key autophagy genes display perinatal death and lethal neurotoxicity, respectively, limiting their applications for in vivo studies. Here, we have developed an inducible shRNA mouse model targeting Atg5, allowing us to dynamically inhibit autophagy in vivo, termed ATG5i mice. The lack of brain-associated shRNA expression in this model circumvents the lethal phenotypes associated with complete autophagy knockouts. We show that ATG5i mice recapitulate many of the previously described phenotypes of tissue-specific knockouts. While restoration of autophagy in the liver rescues hepatomegaly and other pathologies associated with autophagy deficiency, this coincides with the development of hepatic fibrosis. These results highlight the need to consider the potential side effects of systemic anti-autophagy therapies.
Source: Autophagy
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $855
Awards: G1255154260, G1524023739, G1718211178, Hedgehog signalling in T cell effector and memory function in vivo., G2595365970, Vascular endothelium as the amplifying machinery of oncogene-induced senescence surveillance, G4273598029, Literature-based discovery for cancer biology, G4512790425, Cellular Medicine at the Cambridge Institute for Medical Research., G5106827998, G5648615834, G5833099561, G5841570098, G6274671817, G640145969, G7330469441, G7347995879, G8086268091, Autophagy in health and disease., NORMAL & NEOPLASTIC GROWTH IN THE BRAIN
OpenAlex ID: W2788593479
